Atsushi Usami studied pharmacology and neuroscience and received a Ph.D. In pharmaceutical sciences from the University of Tokyo and is a pharmacist.
He focuses on seed/early-stage life science investments. He served on the boards of Repertoire Genesis Inc. and currently serves on the boards of EditForce Inc., Bugworks Research inc., bitBiome Inc., OriCiro Genomics, Inc., and RegCell Co., Ltd. Before joining UTEC, he worked as a strategy consultant at Mitsubishi Research Institute (MRI), serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development.

What I expect of LINK-J

I'm very happy to work as a supporter for LINK-J to create platforms for new life-science industries. I'm looking forward to further accelerating open innovation across countries and fields through LINK-J initiatives.

Message to LINK-J Special Members

I hope that we will be able to pioneer frontiers of new industries with LINK-J members.